-
Loading metrics
A Phase-I pharmacokinetic, safety and food-effect study on flubentylosin, a novel analog of Tylosin-A having potent anti-Wolbachia and antifilarial activity
-
Negar Alami ,
Roles Conceptualization, Data curation, Investigation, Methodology, Supervision, Writing – original draft
* E-mail: nalami03@gmail.com
Affiliations AbbVie, North Chicago, Illinois, United States of America, Pfizer, Chicago, Illinois, United States of America
⨯ - David C. Carter,
- Nisha V. Kwatra,
- Weihan Zhao,
- Linda Snodgrass,
- Ariel R. Porcalla,
- Cheri E. Klein,
- Daniel E. Cohen,
- Loretta Gallenberg,
- Melina Neenan,
- Robert A. Carr,
- Kennan C. Marsh,
- Dale J. Kempf
https://orcid.org/0000-0003-4455-5780
A Phase-I pharmacokinetic, safety and food-effect study on flubentylosin, a novel analog of Tylosin-A having potent anti-Wolbachia and antifilarial activity
- Negar Alami,
- David C. Carter,
- Nisha V. Kwatra,
- Weihan Zhao,
- Linda Snodgrass,
- Ariel R. Porcalla,
- Cheri E. Klein,
- Daniel E. Cohen,
- Loretta Gallenberg,
- Melina Neenan
x
-
- Published: July 10, 2023
- https://doi.org/10.1371/journal.pntd.0011392